sean pittock, ectrims 2022: phase 3 champion-nmosd trial results – ravulizumab for aqp4-igg nmosd
Published 1 year ago • 223 plays • Length 6:43Download video MP4
Download video MP3
Similar videos
-
8:00
sean pittock, ean 2020 – phase 3 prevent study insights in neuromyelitis optica spectrum disorder
-
5:04
barry singer, ectrims 2022: diroximel fumarate for rrms – phase 3 results from evolve-ms-1
-
1:27
protocol test extreme testing by essilor (original version)
-
0:18
tuberous sclerosis
-
1:00:08
approved nmosd therapies
-
1:35
what is multiple sclerosis?
-
32:17
neuromyelitis optica spectrum disorder by dr bimsara senanayake
-
1:10
how long does the treatment last?
-
3:05
synaptive modus v™ - c3-c6 laminectomy
-
3:19
aan16 takeaways: sean pittock, m.d.
-
0:51
superb micro-vascular imaging (smi)
-
0:16
anisotropy of the carpal tunnel on ultrasound
-
3:11
compression system application video for hip spica
-
3:35
post hoc analysis: phase 3 expand trial in secondary progressive ms
-
0:10
mskus ultrasound - anterior bundle ssp and rotator cable connected to chl
-
0:30
modus ir cranial avm
-
1:19
optic neuritis